Robert C. Getts

Director/Board Member at Genisphere LLC

Consumer Services

Electronic Technology

Profile

Robert C.
Getts is currently a Director at Genisphere LLC.
Previously, he worked as a Principal at Philadelphia College of Osteopathic Medicine.
He holds a doctorate degree from Lehigh University and undergraduate and graduate degrees from the University of Scranton.

Robert C. Getts active positions

Companies	Position	Start
Genisphere LLC Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA.	Director/Board Member	-

All active positions of Robert C. Getts

Former positions of Robert C. Getts

Companies	Position	End
Philadelphia College of Osteopathic Medicine	Corporate Officer/Principal	-

See the detail of Robert C. Getts's experience

Training of Robert C. Getts

University of Scranton	Graduate Degree
Lehigh University	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert C. Getts's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Genisphere LLC Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA.	Electronic Technology